These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27793476)

  • 1. Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older.
    Froehner M; Koch R; Hübler M; Zastrow S; Wirth MP
    Eur Urol; 2017 May; 71(5):710-713. PubMed ID: 27793476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Froehner M; Koch R; Heberling U; Novotny V; Hübler M; Wirth MP
    Urol Oncol; 2017 Jan; 35(1):32.e17-32.e23. PubMed ID: 27519277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of education and mortality after radical prostatectomy.
    Froehner M; Koch R; Propping S; Liebeheim D; Hübler M; Baretton GB; Hakenberg OW; Wirth MP
    Asian J Androl; 2017; 19(2):173-177. PubMed ID: 28051039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an Age-adjusted Prostate Cancer-Specific Comorbidity Index.
    Froehner M; Koch R; Hübler M; Wirth MP
    Eur Urol; 2016 May; 69(5):764-6. PubMed ID: 26558839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
    Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy.
    Froehner M; Koch R; Litz R; Oehlschlaeger S; Noack B; Manseck A; Albrecht DM; Wirth MP
    Urology; 2003 Mar; 61(3):596-600. PubMed ID: 12639654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy.
    Boehm K; Larcher A; Tian Z; Mandel P; Schiffmann J; Karakiewicz PI; Graefen M; Huland H; Tilki D
    J Urol; 2016 Jul; 196(1):82-8. PubMed ID: 26925872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
    Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
    Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.
    Froehner M; Kellner AE; Koch R; Baretton GB; Hakenberg OW; Wirth MP
    BMC Urol; 2014 Mar; 14():28. PubMed ID: 24678762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Froehner M; Muallah D; Koch R; Hübler M; Borkowetz A; Heberling U; Huber J; Wirth MP; Thomas C
    Urol Int; 2020; 104(1-2):62-69. PubMed ID: 31639810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy.
    Daskivich TJ; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Freedland SJ
    J Urol; 2020 Sep; 204(3):511-517. PubMed ID: 32243242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
    Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
    Froehner M; Koch R; Hübler M; Renner T; Borkowetz A; Zastrow S; Wirth MP
    Eur Urol Focus; 2019 May; 5(3):361-364. PubMed ID: 29426695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
    Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
    Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
    J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    BJU Int; 2012 Jul; 110(2):206-10. PubMed ID: 22044591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which comorbidity classification best fits elderly candidates for radical prostatectomy?
    Froehner M; Hentschel C; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    Urol Oncol; 2013 May; 31(4):461-7. PubMed ID: 21498089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.